Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01753921 · ClinicalTrials.gov registry record

Evaluation of a Non-invasive Brain Compliance Measurement Device

A clinical trial of Diabetes and Diabetic Ketoacidosis, sponsored by Stanford University.

Compiled by PlainTrial · August 8, 2026

Completed
Registry status: 14
Enrollment target: 1
Study location

NCT01753921: Completed study of Diabetes and Diabetic Ketoacidosis, sponsored by Stanford University.

NCT01753921 is a study of Diabetes and Diabetic Ketoacidosis that has completed, run by Stanford University. The registered enrollment target is 14 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01753921, a study of Diabetes and Diabetic Ketoacidosis, has completed, sponsored by Stanford University.

COMPLETED
Registry status: 14 participants
Enrollment target: 1
Study location

Study Summary

This is a research study to understand how diabetic ketoacidosis may affect the brain and learning and to see if these changes are transient or permanent. The investigators hope to learn more about how diabetic ketoacidosis may cause changes in brain compliance (by wearing a non-invasive head band/helmet like device from Jan Medical: The Nautilus Neurowave System™ (NNS), learning, talking, behavior, or development. The investigators will compare those results from those with diabetes mellitus to those age and gendered matched healthy controls. Possible subjects in this study have diabetes mellitus and are between the ages of 10 to less than 17 years old OR do NOT have diabetes and are between the ages of 10 to less than 17 years old.

Primary Outcome

We will be using the brain compliance measurement device to see if there is a unique signal for those with DKA and if so, follow the duration of this signal.

Conditions Studied

Diabetes Diabetic Ketoacidosis

Interventions

DEVICE MRI
OTHER this is not an intervention study

Study Locations (1)

California

Stanford University - Stanford

Trial Details

Field	Value
Enrollment Target	14 participants
Start Date	2011-11
Est. Completion	2016-10

Stanford University

1,744 total trials

What the finished NCT01753921 record still lists

NCT01753921 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT01753921 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01753921 about?

NCT01753921 is a clinical study titled "Evaluation of a Non-invasive Brain Compliance Measurement Device". This is a research study to understand how diabetic ketoacidosis may affect the brain and learning and to see if these changes are transient or permanent. The investigators hope to learn more about how diabetic ketoacidosis may cause changes in brain compliance (by wearing a non-invasive head band/h...

What is the current status of trial NCT01753921?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2011-11. Estimated completion is 2016-10.

What conditions does trial NCT01753921 study?

This clinical trial studies the following conditions: Diabetes, Diabetic Ketoacidosis.

What interventions are being tested in trial NCT01753921?

The interventions under investigation include: MRI (DEVICE), this is not an intervention study (OTHER).

Who is sponsoring clinical trial NCT01753921?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01753921 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01753921's enrollment target sits among peer trials

14 325th of 338 higher than 14 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
NCT04743271 · 14 participants · NA
Food and Circadian Timing
NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01753921, the US trial registry maintained by the National Library of Medicine. NCT01753921 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.